{"lead_paragraph": "Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new United States drugs to its highest level in 19 years.", "pub_date": "2016-01-05T00:00:00Z", "slideshow_credits": null, "byline": {"contributor": "", "organization": "THE ASSOCIATED PRESS", "person": [], "original": "By THE ASSOCIATED PRESS"}, "document_type": "article", "section_name": "Business Day", "snippet": "Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new United States drugs to its highest level in 19 years.", "multimedia": [], "blog": [], "type_of_material": "Brief", "headline": {"main": "F.D.A. Drug Approvals Climb to Highest Level Since 1996", "print_headline": "F.D.A. Drug Approvals Climb to Highest Level Since 1996", "content_kicker": "Business Briefing"}, "keywords": [{"rank": "1", "name": "subject", "is_major": "Y", "value": "Drugs (Pharmaceuticals)"}, {"rank": "2", "name": "organizations", "is_major": "Y", "value": "Food and Drug Administration"}], "web_url": "http://www.nytimes.com/2016/01/05/business/fda-drug-approvals-climb-to-highest-level-since-1996.html", "print_page": "2", "source": "The New York Times", "news_desk": "Business", "abstract": "Food and Drug Administration approved 45 drugs with never-before-sold ingredients in 2015, highest number since 1996.", "word_count": "163", "_id": "568b050a38f0d85e74bd0b3e", "subsection_name": null}